LEGISLATION TESTIMONY/ADVOCACY STATEMENT

LEGISLATION TESTIMONY/ADVOCACY STATEMENT 1 Legislation Testimony/Advocacy Statement Walden University Author’s note Submitted for NURS - 6050C Policy and Advocacy for Improving Population Health, Instructor Faisal Aboul-Enein on December 22, 2019 This study source was downloaded by from CourseH on :42:07 GMT -05:00 LEGISLATION TESTIMONY/ADVOCACY STATEMENT 2 Legislation Testimony/Advocacy Statement Nurses are offered the unique opportunity to shape and influence future health policy, therefore, nurses must be active in legislation to advocate for patients ensuring quality of care is maintained and access to healthcare is ensured (Laureate Education, 2018). This paper will recommend a bill utilizing a comparison grid and Testimony/Advocacy statement. Part 1 Legislation Comparison Grid Template Health-related Bill Name Patients' Right to Know Their Medication Act of 2019 Bill Number H.R.5198 — 116th Congress () Description To amend the Federal Food, Drug, and Cosmetic Act regarding the patient medication information required to be included in the labeling of prescription drugs, and for other purposes. Federal or State? Federal Legislative Intent The legislative intent is to issue regulations patient medication information that is required to be in the printed labeling of drugs subject to section 503(b)(1), including regulations regarding the authorship, content, format, color, printing, and dissemination requirements for such patient medication information. Proponents/ Opponents Proponents: Jared Golden D- ME Buddy Carter R-GA Opponents: There is no opponents currently this bill, it is still in summary. Target Population All Americans are targeted in this bill. It is documented that 48.9 percent of Americans used at least one prescription drug in the past 30 days, consequently, the utilization of prescription drugs can subject This study source was downloaded by from CourseH on :42:07 GMT -05:00 LEGISLATION TESTIMONY/ADVOCACY STATEMENT 3 patients to adverse drug events. Status of the bill (Is it in hearings or committees? Is it receiving press coverage?) This bill was introduced November 20, 2019. Presently this bill in the House Energy and Commerce Committee. This bill is not receiving press coverage. It has a 1 % chance of enactment at present. General Notes/Comments As of 12/22/2019 a CBO Cost Estimate for this measure has not been received. (2019)